AIMS/HYPOTHESIS: We examined race differences in the association between age at menarche and type 2 diabetes before and after adjustment for adiposity. METHODS: We analysed baseline and 9-year follow-up data from 8,491 women (n = 2,505 African-American, mean age 53.3 years; n = 5,986 white, mean age 54.0 years) in the Atherosclerosis Risk in Communities (ARIC) study. Stratifying by race, we used logistic regression to estimate the OR for prevalent diabetes at baseline, and Cox proportional hazard models to estimate the HR for incident diabetes over follow-up according to age at menarche category (8-11, 12, 13, 14 and 15-18 years). RESULTS: Adjusting for age and centre, we found that early age at menarche (8-11 vs 13 years) was associated with diabetes for white, but not African-American women in both the prevalent (white OR 1.72, 95% CI 1.32, 2.25; African-American OR 1.13, 95% CI 0.84, 1.51; interaction p = 0.043) and incident models (white HR 1.43, 95% CI 1.08, 1.89; African-American HR 1.20, 95% CI 0.87, 1.67; interaction p = 0.527). Adjustment for adiposity and lifestyle confounders attenuated associations for prevalent (white OR 1.41, 95% CI 1.05, 1.89; African-American OR 0.94, 95% CI 0.68, 1.30; interaction p = 0.093) and incident diabetes (white HR 1.22, 95% CI 0.92, 1.63; African-American HR 1.11, 95% CI 0.80, 1.56; interaction p = 0.554). CONCLUSIONS/ INTERPRETATION: Early menarche was associated with type 2 diabetes in white women, and adulthood adiposity attenuated the relationship. We did not find a similar association in African-American women. Our findings suggest that there may be race/ethnic differences in the influence of developmental factors in the aetiology of type 2 diabetes, which merit further investigation.
AIMS/HYPOTHESIS: We examined race differences in the association between age at menarche and type 2 diabetes before and after adjustment for adiposity. METHODS: We analysed baseline and 9-year follow-up data from 8,491 women (n = 2,505 African-American, mean age 53.3 years; n = 5,986 white, mean age 54.0 years) in the Atherosclerosis Risk in Communities (ARIC) study. Stratifying by race, we used logistic regression to estimate the OR for prevalent diabetes at baseline, and Cox proportional hazard models to estimate the HR for incident diabetes over follow-up according to age at menarche category (8-11, 12, 13, 14 and 15-18 years). RESULTS: Adjusting for age and centre, we found that early age at menarche (8-11 vs 13 years) was associated with diabetes for white, but not African-American women in both the prevalent (white OR 1.72, 95% CI 1.32, 2.25; African-American OR 1.13, 95% CI 0.84, 1.51; interaction p = 0.043) and incident models (white HR 1.43, 95% CI 1.08, 1.89; African-American HR 1.20, 95% CI 0.87, 1.67; interaction p = 0.527). Adjustment for adiposity and lifestyle confounders attenuated associations for prevalent (white OR 1.41, 95% CI 1.05, 1.89; African-American OR 0.94, 95% CI 0.68, 1.30; interaction p = 0.093) and incident diabetes (white HR 1.22, 95% CI 0.92, 1.63; African-American HR 1.11, 95% CI 0.80, 1.56; interaction p = 0.554). CONCLUSIONS/ INTERPRETATION: Early menarche was associated with type 2 diabetes in white women, and adulthood adiposity attenuated the relationship. We did not find a similar association in African-American women. Our findings suggest that there may be race/ethnic differences in the influence of developmental factors in the aetiology of type 2 diabetes, which merit further investigation.
Authors: Ellen W Demerath; Jianrong Li; Shumei S Sun; W Cameron Chumlea; Karen E Remsberg; Stefan A Czerwinski; Bradford Towne; Roger M Siervogel Journal: Am J Clin Nutr Date: 2004-08 Impact factor: 7.045
Authors: Isabel dos Santos Silva; Bianca L De Stavola; Vera Mann; Diana Kuh; Rebecca Hardy; Michael E J Wadsworth Journal: Int J Epidemiol Date: 2002-04 Impact factor: 7.196
Authors: D Michael Freedman; Robert E Tarone; Michele M Doody; Aparna Mohan; Bruce H Alexander; John D Boice; Martha S Linet Journal: Ann Epidemiol Date: 2002-08 Impact factor: 3.797
Authors: David S Freedman; Laura Kettel Khan; Mary K Serdula; William H Dietz; Sathanur R Srinivasan; Gerald S Berenson Journal: Pediatrics Date: 2002-10 Impact factor: 7.124
Authors: Ellen W Demerath; Bradford Towne; W Cameron Chumlea; Shumei S Sun; Stefan A Czerwinski; Karen E Remsberg; Roger M Siervogel Journal: Am J Hum Biol Date: 2004 Jul-Aug Impact factor: 1.937
Authors: Mary Beth Terry; Mandy Goldberg; Sarah Schechter; Lauren C Houghton; Melissa L White; Karen O'Toole; Wendy K Chung; Mary B Daly; Theresa H M Keegan; Irene L Andrulis; Angela R Bradbury; Lisa Schwartz; Julia A Knight; Esther M John; Saundra S Buys Journal: Pediatrics Date: 2016-06-08 Impact factor: 7.124
Authors: Jeong Han Sim; Dawn Chung; Jung Soo Lim; Mi Young Lee; Choon Hee Chung; Jang Yel Shin; Ji Hye Huh Journal: PLoS One Date: 2015-05-26 Impact factor: 3.240
Authors: Cathy E Elks; Ken K Ong; Robert A Scott; Yvonne T van der Schouw; Judith S Brand; Petra A Wark; Pilar Amiano; Beverley Balkau; Aurelio Barricarte; Heiner Boeing; Ana Fonseca-Nunes; Paul W Franks; Sara Grioni; Jytte Halkjaer; Rudolf Kaaks; Timothy J Key; Kay Tee Khaw; Amalia Mattiello; Peter M Nilsson; Kim Overvad; Domenico Palli; J Ramón Quirós; Sabina Rinaldi; Olov Rolandsson; Isabelle Romieu; Carlotta Sacerdote; María-José Sánchez; Annemieke M W Spijkerman; Anne Tjonneland; Maria-Jose Tormo; Rosario Tumino; Daphne L van der A; Nita G Forouhi; Stephen J Sharp; Claudia Langenberg; Elio Riboli; Nicholas J Wareham Journal: Diabetes Care Date: 2013-11 Impact factor: 19.112